Paclitaxel (2nd) contains not less than 97.0 percent and not more than 102.0 percent of C47H51NO14 calculated on the anhydrous basis.

申請商
台灣神隆股份有限公司 
適應症
抗腫瘤用藥/ 有絲分裂抑制劑。
含量
0